BMY
NYSE Bristol-Myers Squibb Company$62.96 ↑ +0.56 (+0.90%) Trading Up from the previous close of $62.40, $1.17 below the day’s high of $64.13
- YTD change
- +16.72%
- vs 20-day SMA
- -1.66%
- vs 200-day SMA
- +6.24%
Price ranges
Price & Performance
+2.67 (+4.47%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 22.7% away from all-time highs of $81.44
- BMY is up 17% since the beginning of the year
- BMY is up 40% over the past 12 months
- BMY is down 6% over the past 1 month
- 2% of all BMY investors are betting against BMY
- Number of investors short BMY has gone down 20% versus last month
BMY reads neutral: price sits above one of the two key moving averages, short interest is falling month over month, the 12-month move is +38.4%.
- Previous minute
- -$0.37
- Last hour
- +$0.46
- Last 5 days
- +1.14%
- vs 8-day SMA
- +0.70%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.
Competitor comparison
No peer group available for this symbol.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.